A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.